ALX ONCOLOGY HOLDINGS INC 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0000950170-25-107303
- Form type
- 10-Q
- CIK
- 0001810182
- Primary document
- https://www.sec.gov/Archives/edgar/data/1810182/000095017025107303/alxo-20250630.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for ALX ONCOLOGY HOLDINGS INC.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-58.5M | - | - |
| Net Income | $-56.7M | - | - |
| Eps Basic | -1.05 | - | - |
| Eps Diluted | -1.05 | - | - |
| Cash And Equivalents | $19.3M | - | - |
| Total Assets | $95.3M | - | - |
| Total Liabilities | $30.9M | - | - |
| Shareholders Equity | $64.4M | - | - |
| Operating Cash Flow | $-48.1M | - | - |
| Capital Expenditures | $107,000 | - | - |